We are live on ! Find out more
RXL icon

ProShares Ultra Health Care

22 hedge funds and large institutions have $13.4M invested in ProShares Ultra Health Care in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

7.09% less ownership

Funds ownership: 25.35%18.25% (-7.1%)

15% less funds holding

Funds holding: 2622 (-4)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

41% less capital invested

Capital invested by funds: $22.7M → $13.4M (-$9.33M)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
22
Holders Change
-4
Holders Change %
-15.38%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
7
Closed
9
Calls
$450K
Puts
Net Calls
+$450K
Net Calls Change
-$829K

RXL Hedge Fund Activity: Q1 2022 in Review

22 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q1 2022, worth a combined $13.4M — down 41% from $22.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of RXL and 5 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 5 added.

The largest buyer was IMC Chicago, adding an estimated $2.81M. The largest seller was Geneos Wealth Management, exiting entirely with an estimated $7.74M sold.

  • 22 institutional investors held ProShares Ultra Health Care (RXL) as of Q1 2022, down from 26 in Q4 2021.
  • Funds reported $13.4M of ProShares Ultra Health Care stock for Q1 2022, down 41% quarter-over-quarter.
  • 5 funds opened new ProShares Ultra Health Care positions in Q1 2022 and 9 closed out, a net change of -4 holders.
  • The largest ProShares Ultra Health Care buyer in Q1 2022 was IMC Chicago, an estimated $2.81M added.
  • The largest ProShares Ultra Health Care seller in Q1 2022 was Geneos Wealth Management, an estimated $7.74M sold.

Based on aggregated 13F filings for Q1 2022.